Usage of Rotarix® in neonatal units across the United Kingdom

Hussain Alsaffar, Katherine Woodger, Ignatius Losa*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Following advice and recommendations by the Joint Committee on Vaccination and Immunisation (JCVI), and in line with standing commitments on patient rights under the NHS constitution on implementing such recommendations, a series of changes to England's national immunisation programme took place from July 2013 including the introduction of Rotavirus vaccine (Rotarix® by GlaxoSmithKline Biologicals s.a.) into the routine childhood UK schedule for babies from 2 months of age [1].

Original languageEnglish
Article number1000240
JournalJournal of Vaccines and Vaccination
Issue number4
Publication statusPublished - 2014
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Drug Discovery
  • Virology

Cite this